John L. Ziegler

from Wikipedia, the free encyclopedia

John L. Ziegler (born October 28, 1938 ) is an American medic .

Ziegler studied first from 1956 at Amherst College with the main subject English (Bachelor and Master degree) and from 1960 medicine at Cornell University (Medical College) with the MD 1964. His internship he did at Bellevue Hospital and from 1966 he was at the National Cancer Institute . From 1967 to 1972 he headed the Uganda Cancer Institute in Kampala , where he organized the fight against Burkitt's lymphoma with chemotherapy drugs such as Cytoxan and tested combination drugs . In 200 patients, he found 90 percent remission after just one dose and a five-year survival rate of 67 percent.

In 1972 he became director of pediatric oncology at NCI, where he became deputy clinic director in 1975. He also taught at George Washington University and Georgetown University in Washington DC From 1981 he was at the Veterans Affairs Medical Center in San Francisco (as Associate Chief of Staff for Education and Staff Physician) and was a professor at the University of California, San Francisco, where he retired in 1996. In San Francisco from the 1980s onwards he was particularly concerned with comorbidities associated with the AIDS epidemic (Kaposi's sarcoma, non-Hodgkin lymphoma). He later led the cancer risk program of the Helen Diller Family Comprehensive Cancer Center at UCSF and founded the Graduate Program in Public Health.

From 1992 to 1993 he was visiting professor at Cambridge and from 1990/91 and from 1994 to 1996 he was visiting professor at Makerere University in Kampala , where he already taught during his time as director of the Uganda Cancer Institute. In 1996/97 he received an M.Sc. in Epidemiology from the London School of Hygiene and Tropical Medicine, where he was visiting professor from 1992 to 1996.

In 1972 he received the Lasker ~ DeBakey Clinical Medical Research Award . In 2014 he received the Burkitt Award.

Web links

Individual evidence

  1. ^ Lasker Award 1972